UNSPSC 51162725: Guaiacol propionate

This classification denotes a topical anti-infective agent and expectorant with the molecular formula C10H12O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z7SCO70Q61. Most nations, for tariff and trade purposes, schedule guaiacol propionate under HS 29095000. As of Q4 2014, GUAIACOL PROPIONATE remains US FDA's Preferred Term for this commodity. SMILES: CCC(=O)OC1CCCCC1OC.

UNSPSC 51162725 Guaiacol propionate is a Commodity code that in recent state and local procurement activity covers pharmaceutical ingredients and finished parenteral products — intravenous solutions, parenteral nutrition preparations, and related medical compounds — supplied to correctional healthcare systems and public health agencies. The Washington State Department of Corrections and Seminole County, Florida have both posted solicitations under this code in recent months, though the code's nominal scope (guaiacol propionate, a specific chemical compound) does not clearly map to the parenteral products and naloxone systems being solicited. State and local issuing bodies using this code include state correctional departments and county health and public safety agencies; the Washington DOC solicitation targets multiple facilities across regions, indicating a multi-site contracting approach. The work spans healthcare product supply — from specialized pharmacy services (parenteral nutrition solutions prepared and delivered within tight windows, lab-result monitoring, and formula adjustment) to public health commodities (naloxone, drug deactivation systems).

The code sees recent activity in Washington and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, due October 7, 2026, for parenteral products and services to supply eight correctional facilities, with pre-bid on September 23, 2026 and set-aside goals for small, minority-owned, women-owned, and veteran-owned businesses totaling roughly 46 percent across all categories. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to a single community health facility. The mismatch between the code's nominal chemical definition and the actual parenteral-products procurement scope suggests the code may be a catch-all taxonomy assignment by the issuing bodies rather than a precise match to guaiacol propionate itself; the code shows little relevant recent activity specific to the named chemical compound.